Clinical Trial Update: To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating whether ritonavir or omeprazole affects exposure to samatasvir (IDX719) in healthy participants; the MK-1894-006 trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Omeprazole (Omeprazole)
• Ritonavir (Ritonavir)
• Samatasvir (IDX719) (samatasvir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C Infection | Phase 1 | Status: COMPLETED